Atlas Trials

Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes

Clinical trial NCT05440591 · UNKNOWN

Trial details

NCT number
NCT05440591
Sponsor
Tan Tock Seng Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes
Start date
2019-04-01
Primary completion
2023-05-10
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.